首页 / 院系成果 / 成果详情页

Xuebijing Injection Combined with Antibiotics for the Treatment of Spontaneous Bacterial Peritonitis in Liver Cirrhosis: A Meta-Analysis  期刊论文  

  • 编号:
    137e50f8-717b-4488-b1ce-d34fdb126494
  • 作者:
    Han, Dan#[1,2]Wang, Ran[1];Yu, Yang[2];Sun, Mingyu(孙明瑜)[3]Teschke, Rolf[4,5];Romeiro, Fernando Gomes[6];Mancuso, Andrea[7];Song, Tingxue[1,2];Peng, Zhong[1,8];Han, Bing[9];Zhou, Xinmiao[9];Bao, Wenchun[1,2];Li, Qianqian[1,8];Zheng, Kexin[1,9];Li, Yingying[1,9];Bai, Zhaohui[1,10];Guo, Xiaozhong*[1,2]Qi, Xingshun*[1]
  • 语种:
    英文
  • 期刊:
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE ISSN:1741-427X 2018 年 2018 卷
  • 收录:
  • 摘要:

    Background and Aim. Spontaneous bacterial peritonitis (SBP) is one of the most common complications of liver cirrhosis. Antibiotics are the main treatment regimen of SBP. Traditional Chinese medicine Xuebijing injection has been used in such patients. Our study aimed to overview the efficacy of Xuebijing injection combined with antibiotics for the treatment of SBP. Method. We searched the PubMed, Embase, China National Knowledge Infrastructure, VIP, and Wanfang databases. The search items included "Xuebijing", "peritonitis", "liver cirrhosis", and "random" to identify all relevant randomized controlled trials (RCTs). The Cochrane risk of bias tool was used to assess the study quality. The odd ratios (ORs) with 95% confidence intervals (CIs) were calculated by using a random-effect model. Heterogeneity was also calculated. Results. A total of 9 RCTs were included. The study quality was unsatisfied. The overall (OR = 2.95, 95% CI = 1.97-4.42, P < 0.00001) and complete (OR = 2.18, 95% CI = 1.57-3.04, P < 0.00001) responses were significantly higher in the Xuebijing injection combined with antibiotics group than the antibiotics alone group. The incidence of cirrhosis related complications, including hepatic encephalopathy and hepatorenal syndrome, was lower in the Xuebijing injection combined with antibiotics group than the antibiotics alone group. No significant heterogeneity was observed among studies. Conclusion. Additional use of Xuebijing injection may improve the efficacy of antibiotics for the treatment of SBP in liver cirrhosis. However, due to a low level of current evidence, we did not establish any recommendation regarding the use of Xuebijing injection for the treatment of SBP.

  • 推荐引用方式
    GB/T 7714:
    Han Dan,Wang Ran,Yu Yang, et al. Xuebijing Injection Combined with Antibiotics for the Treatment of Spontaneous Bacterial Peritonitis in Liver Cirrhosis: A Meta-Analysis [J].EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE,2018,2018.
  • APA:
    Han Dan,Wang Ran,Yu Yang,Sun Mingyu,&Qi Xingshun.(2018).Xuebijing Injection Combined with Antibiotics for the Treatment of Spontaneous Bacterial Peritonitis in Liver Cirrhosis: A Meta-Analysis .EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE,2018.
  • MLA:
    Han Dan, et al. "Xuebijing Injection Combined with Antibiotics for the Treatment of Spontaneous Bacterial Peritonitis in Liver Cirrhosis: A Meta-Analysis" .EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE 2018(2018).
  • 入库时间:
    1/6/2020 6:08:08 PM
  • 更新时间:
    1/6/2020 6:08:08 PM
  • 条目包含文件:
    文件类型:PDF,文件大小:
    正在加载全文
浏览次数:100 下载次数:0
浏览次数:100
下载次数:0
打印次数:0
浏览器支持: Google Chrome   火狐   360浏览器极速模式(8.0+极速模式) 
返回顶部